NASDAQ:HVII · NASDAQ Global Select
-$0.01 today
Vol 0.00M · Avg 0.05M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Hennessy Capital Investment Corp. VII earnings power becomes long-term shareholder value. Use this page to compare HVII returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
2.0%
avg 105.4%
ROIC
-1.8%
avg -5.7%
ROA
1.9%
avg -1.5%
Analysis
ROE is currently the strongest return metric at 2.0% versus its period average of 105.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Nicholas Boris Geeza | Executive Vice President, Chief Financial Officer & Secretary | — | — | 40 | — | — |
Thomas Daniel Hennessy | President, Chief Operating Officer & Director | — | — | 41 | — | — |
Daniel Joseph Hennessy | Chairman of the Board of Directors & Chief Executive Officer | — | — | 69 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
$359.09M
Bold Eagle Acquisition Corp.
NASDAQ:BEAG
$335.10M
Andretti Acquisition Corp. II
NASDAQ:POLE
$318.41M
Artius II Acquisition Inc. Class A Ordinary Shares
NASDAQ:AACB
$291.14M
Soulpower Acquisition Corp.
NYSE:SOUL
$265.69M
Oaktree Acquisition Corp. II
NASDAQ:OACC
$264.02M
Plum Acquisition Corp. IV
NASDAQ:PLMK
$258.67M
FACT II Acquisition Corp
NASDAQ:FACT
$258.54M
Armada Acquisition Corp. III
NASDAQ:AACI
$255.22M
Roman DBDR Acquisition Corp. II
NASDAQ:DRDB
$242.65M
Who manages HVII?
Hennessy Capital Investment Corp. VII (HVII) lists 3 active executives. The top listed executive is Nicholas Boris Geeza, Executive Vice President, Chief Financial Officer & Secretary.
Explore More
Continue the stock analysis
Jump to another research area for this company.